Phase 1UnknownINTERVENTIONAL
Assessing Ketorolac (Toradol) at Oocyte Retrieval
ClinicalTrials.gov · NCT06026553 · Registry updated: 2023-09-07
- Condition / research focus
- Infertility; Infertility, Female; Oocyte Retrieval; Postoperative Pain; Embryo Transfer
- Sponsor
- Shady Grove Fertility Reproductive Science Center
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2022-08-10. Completion: 2025-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Ketorolac (Toradol) (drug)
- Placebo (saline) (other)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Shady Grove Fertility Reproductive Science Center
Rockville, Maryland, United States
Site recruitment: Recruiting - Shady Grove Fertility Reproductive Science Center
Fairfax, Virginia, United States
Site recruitment: Recruiting